Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional Study
1 other identifier
observational
57
1 country
1
Brief Summary
Cystic fibrosis (CF) is the most common lethal, inherited disorder among Caucasians. Choline is an essential vitamin and as a methyl donor is critically needed to support the normal metabolism. Our previous studies have demonstrated that children with CF have depleted levels of choline. The purpose of this study is to gather data on the status of choline and related metabolites in children with Cystic Fibrosis by age and gender. The hypothesis for this study is that in children with CF, deficiency of choline and related metabolites will increase with increasing age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 26, 2010
CompletedFirst Posted
Study publicly available on registry
June 24, 2010
CompletedApril 22, 2015
April 1, 2015
1.4 years
April 26, 2010
April 21, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change in plasma choline and its metabolites with increasing age in children with CF compared to a healthy reference group without CF
12 months
Secondary Outcomes (1)
The relationship between choline and acetylcholine, and markers of oxidative stress, inflammation and disturbed methyl metabolism
12 months
Study Arms (1)
1
Children with proven CF and known genotype, age 0-17 yr
Eligibility Criteria
Children with proven CF and known genotype, age 0-17 yr who are outpatients of the CF Clinic at the British Columbia (B.C.) Children's Hospital
You may qualify if:
- children with proven CF and known genotype.
- age 0-17 yr.
- outpatients of the CF Clinic at the British Columbia (B.C.) Children's Hospital.
- Children without CF or any other known disease.
You may not qualify if:
- children with CF receiving parenteral nutrition during the previous week.
- children who are hospitalized.
- children with any health problems other than CF that might in the opinion of the investigators influence dietary choices, growth, choline or methyl metabolites.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of British Columbialead
- Cystic Fibrosis Foundationcollaborator
Study Sites (1)
Child & Family Research Institute, CF Clinic, BC Children's Hospital
Vancouver, British Columbia, Canada
Related Publications (1)
Innis SM, Davidson AG, Bay BN, Slack PJ, Hasman D. Plasma choline depletion is associated with decreased peripheral blood leukocyte acetylcholine in children with cystic fibrosis. Am J Clin Nutr. 2011 Mar;93(3):564-8. doi: 10.3945/ajcn.110.005413. Epub 2011 Jan 12.
PMID: 21228267DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sheila M. Innis, Dr.
University of British Columbia
- STUDY DIRECTOR
A. George F. Davidson, MD
University of British Columbia
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2010
First Posted
June 24, 2010
Study Start
October 1, 2007
Primary Completion
March 1, 2009
Study Completion
March 1, 2009
Last Updated
April 22, 2015
Record last verified: 2015-04